187 related articles for article (PubMed ID: 15360007)
1. Coexpression of CD40 and CD40L on B lymphoma and carcinoma cells: an autocrine anti-apoptotic role.
Voorzanger-Rousselot N; Blay JY
Leuk Lymphoma; 2004 Jun; 45(6):1239-45. PubMed ID: 15360007
[TBL] [Abstract][Full Text] [Related]
2. CD40L induces multidrug resistance to apoptosis in breast carcinoma and lymphoma cells through caspase independent and dependent pathways.
Voorzanger-Rousselot N; Alberti L; Blay JY
BMC Cancer; 2006 Mar; 6():75. PubMed ID: 16545138
[TBL] [Abstract][Full Text] [Related]
3. Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer.
Tong AW; Papayoti MH; Netto G; Armstrong DT; Ordonez G; Lawson JM; Stone MJ
Clin Cancer Res; 2001 Mar; 7(3):691-703. PubMed ID: 11297266
[TBL] [Abstract][Full Text] [Related]
4. Resistance to cytotoxic chemotherapy induced by CD40 ligand in lymphoma cells.
Voorzanger-Rousselot N; Favrot M; Blay JY
Blood; 1998 Nov; 92(9):3381-7. PubMed ID: 9787177
[TBL] [Abstract][Full Text] [Related]
5. The effects of malignant transformation on susceptibility of human urothelial cells to CD40-mediated apoptosis.
Bugajska U; Georgopoulos NT; Southgate J; Johnson PW; Graber P; Gordon J; Selby PJ; Trejdosiewicz LK
J Natl Cancer Inst; 2002 Sep; 94(18):1381-95. PubMed ID: 12237284
[TBL] [Abstract][Full Text] [Related]
6. Coexpression of CD40 and CD40 ligand in B-cell lymphoma cells.
Clodi K; Asgary Z; Zhao S; Kliche KO; Cabanillas F; Andreeff M; Younes A
Br J Haematol; 1998 Oct; 103(1):270-5. PubMed ID: 9792321
[TBL] [Abstract][Full Text] [Related]
7. Immune Check Point CD40-CD40L Activates Dendritic and Effector Cells Against Human Renal Carcinoma Cells.
Hillebrand RM; Vogt A; Strassburg CP; Gonzalez-Carmona MA; Schmidt-Wolf IGH
Anticancer Res; 2019 Sep; 39(9):4643-4652. PubMed ID: 31519562
[TBL] [Abstract][Full Text] [Related]
8. CD40 ligand-mediated activation of the de novo RelB NF-kappaB synthesis pathway in transformed B cells promotes rescue from apoptosis.
Mineva ND; Rothstein TL; Meyers JA; Lerner A; Sonenshein GE
J Biol Chem; 2007 Jun; 282(24):17475-85. PubMed ID: 17446175
[TBL] [Abstract][Full Text] [Related]
9. CD40 Cross-Linking Induces Migration of Renal Tumor Cell through Nuclear Factor of Activated T Cells (NFAT) Activation.
Pontrelli P; Gigante M; Spadaccino F; Netti GS; Saldarelli M; Balducci L; Gigante M; Battaglia M; Storkus WJ; Castellano G; Stallone G; Gesualdo L; Ranieri E
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445576
[TBL] [Abstract][Full Text] [Related]
10. Induction of cytotoxic effector cells towards cholangiocellular, pancreatic, and colorectal tumor cells by activation of the immune checkpoint CD40/CD40L on dendritic cells.
Sadeghlar F; Vogt A; Mohr RU; Mahn R; van Beekum K; Kornek M; Weismüller TJ; Branchi V; Matthaei H; Toma M; Schmidt-Wolf IGH; Kalff JC; Strassburg CP; González-Carmona MA
Cancer Immunol Immunother; 2021 May; 70(5):1451-1464. PubMed ID: 33180184
[TBL] [Abstract][Full Text] [Related]
11. Soluble CD40 ligand (sCD40L) provides a new delivery system for targeted treatment: sCD40L-caspase 3 chimeric protein for treating B-cell malignancies.
Kedar R; Sabag O; Licthenstein M; Lorberboum-Galski H
Cancer; 2012 Dec; 118(24):6089-104. PubMed ID: 22692727
[TBL] [Abstract][Full Text] [Related]
12. CD40 activation in epithelial ovarian carcinoma cells modulates growth, apoptosis, and cytokine secretion.
Gallagher NJ; Eliopoulos AG; Agathangelo A; Oates J; Crocker J; Young LS
Mol Pathol; 2002 Apr; 55(2):110-20. PubMed ID: 11950960
[TBL] [Abstract][Full Text] [Related]
13. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis.
Mach F; Schönbeck U; Sukhova GK; Bourcier T; Bonnefoy JY; Pober JS; Libby P
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1931-6. PubMed ID: 9050882
[TBL] [Abstract][Full Text] [Related]
14. Regulation of cytoplasmic, surface and soluble forms of CD40 ligand in mouse B cells.
Wykes M; Poudrier J; Lindstedt R; Gray D
Eur J Immunol; 1998 Feb; 28(2):548-59. PubMed ID: 9521065
[TBL] [Abstract][Full Text] [Related]
15. Co-expression of CD40/CD40L on XG1 multiple myeloma cells promotes IL-6 autocrine function.
Qi C; Tian S; Wang J; Ma H; Qian K; Zhang X
Cancer Invest; 2015 Jan; 33(1):6-15. PubMed ID: 25514317
[TBL] [Abstract][Full Text] [Related]
16. Transgenic expression of CD40L and interleukin-2 induces an autologous antitumor immune response in patients with non-Hodgkin's lymphoma.
Takahashi S; Yotnda P; Rousseau RF; Mei Z; Smith S; Rill D; Younes A; Brenner MK
Cancer Gene Ther; 2001 May; 8(5):378-87. PubMed ID: 11477458
[TBL] [Abstract][Full Text] [Related]
17. Autocrine TNF-α-mediated NF-κB activation is a determinant for evasion of CD40-induced cytotoxicity in cancer cells.
Li D; Zhong Y; Zhou Y; Sun H; Zheng X; Zhao C; Yan Y; Lin Y; Liao L; Wang X
Biochem Biophys Res Commun; 2013 Jul; 436(3):467-72. PubMed ID: 23751348
[TBL] [Abstract][Full Text] [Related]
18. Human CD14hi monocytes and myeloid dendritic cells provide a cell contact-dependent costimulatory signal for early CD40 ligand expression.
Chakrabarty S; Snyder JT; Shen J; Azmi H; Hu PQ; Chen Q; Ragheb JA
Blood; 2011 Feb; 117(5):1585-94. PubMed ID: 20634374
[TBL] [Abstract][Full Text] [Related]
19. CD40-mediated apoptosis in murine B-lymphoma lines containing mutated p53.
Hollmann AC; Gong Q; Owens T
Exp Cell Res; 2002 Nov; 280(2):201-11. PubMed ID: 12413886
[TBL] [Abstract][Full Text] [Related]
20. Assessment of CD40 and CD40L expression in rheumatoid arthritis patients, association with clinical features and DAS28.
Román-Fernández IV; García-Chagollán M; Cerpa-Cruz S; Jave-Suárez LF; Palafox-Sánchez CA; García-Arellano S; Sánchez-Zuno GA; Muñoz-Valle JF
Clin Exp Med; 2019 Nov; 19(4):427-437. PubMed ID: 31313080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
